XOMA LTD
10-Q, EX-27.1, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: XOMA LTD, 10-Q, 2000-08-14
Next: CAPITOL FEDERAL FINANCIAL, 10-Q, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5


<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              Dec-31-1999
<PERIOD-END>                                   Jun-30-2000
<CASH>                                              42,333
<SECURITIES>                                           713
<RECEIVABLES>                                        3,724
<ALLOWANCES>                                             0
<INVENTORY>                                              0
<CURRENT-ASSETS>                                    47,005
<PP&E>                                              32,333
<DEPRECIATION>                                      28,933
<TOTAL-ASSETS>                                      55,016
<CURRENT-LIABILITIES>                               11,420
<BONDS>                                                  0
<COMMON>                                                33
                                    0
                                              0
<OTHER-SE>                                           4,639
<TOTAL-LIABILITY-AND-EQUITY>                        55,016
<SALES>                                                  0
<TOTAL-REVENUES>                                     2,283
<CGS>                                                    0
<TOTAL-COSTS>                                            0
<OTHER-EXPENSES>                                     8,979
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                     615
<INCOME-PRETAX>                                     (6,326)
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                                 (6,326)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                        (6,326)
<EPS-BASIC>                                          (0.10)
<EPS-DILUTED>                                        (0.10)





</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission